Abstract
Computed tomography (CT) is essential for the diagnosis of liver tumors. In the CT criteria of hypervascular hepatocellular carcinoma (HCC), the diagnosis is based on hemodynamic findings, such as arterial enhancement, followed by washout in the portal-venous and/or equilibrium phase. In this chapter, typical and atypical findings (HCC mimickers) of HCC on CT and current diagnostic techniques to image HCC were stated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bosch FX, Ribes J, Diaz M, Cleries R (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127(5 Suppl 1):S5–S16
Marrero JA, Welling T (2009) Modern diagnosis and management of hepatocellular carcinoma. Clin Liver Dis 13:233–247
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638
El-Serag HB, Tran T, Everhart JE (2004) Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126:460–468
Chen CJ, Yu MW, Liaw YF (1997) Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 12:S294–S308
Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS (2002) NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 36:1349–1354
Matsui O (2004) Imaging of multistep human hepatocarcinogenesis by CT during intra-arterial contrast injection. Intervirology 47:271–276
Hayashi M, Matsui O, Ueda K et al (1999) Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol 172:969–976
Hanna RF, Aguirre DA, Kased N, Emery SC, Peterson MR, Sirlin CB (2008) Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. Radiographics 28:747–769
Park YN, Yang CP, Fernandez GJ, Cubukcu O, Thung SN, Theise ND (1998) Neoangiogenesis and sinusoidal “capillarization” in dysplastic nodules of the liver. Am J Surg Pathol 22:656–662
Roncalli M, Roz E, Coggi G et al (1999) The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification. Hepatology 30:1174–1178
Murakami T, Onishi H, Mikami K et al (2006) Determining the optimal timing for early arterial phase hepatic CT imaging by measuring abdominal aortic enhancement in variable contrast injection protocols. J Comput Assist Tomogr 30:206–211
Noguchi Y, Murakami T, Kim T et al (2003) Detection of hepatocellular carcinoma: comparison of dynamic MR imaging with dynamic double arterial phase helical CT. AJR Am J Roentgenol 180:455–460
Walkey MM (1991) Dynamic hepatic CT: how many years will it take ‘til we learn? Radiology 181:17–18
Brink JA, Heiken JP, Forman HP, Sagel SS, Molina PL, Brown PC (1995) Hepatic spiral CT: reduction of dose of intravenous contrast material. Radiology 197:83–88
Heiken JP, Brink JA, McClennan BL, Sagel SS, Crowe TM, Gaines MV (1995) Dynamic incremental CT: effect of volume and concentration of contrast material and patient weight on hepatic enhancement. Radiology 195:353–357
Takahashi S, Murakami T, Takamura M et al (2002) Multi-detector row helical CT angiography of hepatic vessels: depiction with dual-arterial phase acquisition during single breath hold. Radiology 222:81–88
Tada S, Fukud K, Aoyagi Y, Harada J (1980) CT of abdominal malignancies: dynamic approach. AJR Am J Roentgenol 135:455–461
Young SW, Turner RJ, Castellino RA (1980) A strategy for the contrast enhancement of malignant tumors using dynamic computed tomography and intravascular pharmacokinetics. Radiology 137:137–147
Araki T, Itai Y, Furui S, Tasaka A (1980) Dynamic CT densitometry of hepatic tumors. AJR Am J Roentgenol 135:1037–1043
Dean PB, Violante MR, Mahoney JA (1980) Hepatic CT contrast enhancement: effect of dose, duration of infusion, and time elapsed following infusion. Invest Radiol 15:158–161
Berland LL, Lee JY (1988) Comparison of contrast media injection rates and volumes for hepatic dynamic incremented computed tomography. Invest Radiol 23:918–922
Claussen CD, Banzer D, Pfretzschner C, Kalender WA, Schorner W (1984) Bolus geometry and dynamics after intravenous contrast medium injection. Radiology 153:365–368
Yagyu Y, Awai K, Inoue M et al (2005) MDCT of hypervascular hepatocellular carcinomas: a prospective study using contrast materials with different iodine concentrations. Am J Roentgenol 184:1535–1540
Kormano M, Partanen K, Soimakallio S, Kivimaki T (1983) Dynamic contrast enhancement of the upper abdomen: effect of contrast medium and body weight. Invest Radiol 18:364–367
Awai K, Inoue M, Yagyu Y et al (2004) Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT. Radiology 233:682–688
Han JK, Kim AY, Lee KY et al (2000) Factors influencing vascular and hepatic enhancement at CT: experimental study on injection protocol using a canine model. J Comput Assist Tomogr 24:400–406
Ichikawa T, Erturk SM, Araki T (2006) Multiphasic contrast-enhanced multidetector-row CT of liver: contrast-enhancement theory and practical scan protocol with a combination of fixed injection duration and patients’ body-weight-tailored dose of contrast material. Eur J Radiol 58:165–176
Tomemori T, Yamakado K, Nakatsuka A, Sakuma H, Matsumura K, Takeda K (2001) Fast 3D dynamic MR imaging of the liver with MR SmartPrep: comparison with helical CT in detecting hypervascular hepatocellular carcinoma. Clin Imaging 25:355–361
Kanematsu M, Goshima S, Kondo H et al (2005) Optimizing scan delays of fixed duration contrast injection in contrast-enhanced biphasic multidetector-row CT for the liver and the detection of hypervascular hepatocellular carcinoma. J Comput Assist Tomogr 29:195–201
Awai K, Hiraishi K, Hori S (2004) Effect of contrast material injection duration and rate on aortic peak time and peak enhancement at dynamic CT involving injection protocol with dose tailored to patient weight. Radiology 230:142–150
Awai K, Hori S (2003) Effect of contrast injection protocol with dose tailored to patient weight and fixed injection duration on aortic and hepatic enhancement at multidetector-row helical CT. Eur Radiol 13:2155–2160
Kondo H, Kanematsu M, Goshima S et al (2008) Abdominal multidetector CT in patients with varying body fat percentages: estimation of optimal contrast material dose. Radiology 249:872–877
Erturk SM, Ichikawa T, Sou H, Tsukamoto T, Motosugi U, Araki T (2008) Effect of duration of contrast material injection on peak enhancement times and values of the aorta, main portal vein, and liver at dynamic MDCT with the dose of contrast medium tailored to patient weight. Clin Radiol 63:263–271
Yamashita Y, Komohara Y, Takahashi M et al (2000) Abdominal helical CT: evaluation of optimal doses of intravenous contrast material—a prospective randomized study. Radiology 216:718–723
Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022
Brancatelli G, Federle MP, Ambrosini R et al (2007) Cirrhosis: CT and MR imaging evaluation. Eur J Radiol 61:57–69
Krinsky GA, Lee VS (2000) MR imaging of cirrhotic nodules. Abdom Imaging 25:471–482
Baron RL, Peterson MS (2001) From the RSNA refresher courses: screening the cirrhotic liver for hepatocellular carcinoma with CT and MR imaging: opportunities and pitfalls. Radiographics 21(Spec No(32)):S117–S132
Lim JH, Cho JM, Kim EY, Park CK (2000) Dysplastic nodules in liver cirrhosis: evaluation of hemodynamics with CT during arterial portography and CT hepatic arteriography. Radiology 214:869–874
Lim JH, Kim MJ, Park CK, Kang SS, Lee WJ, Lim HK (2004) Dysplastic nodules in liver cirrhosis: detection with triple phase helical dynamic CT. Br J Radiol 77:911–916
Park YN, Kojiro M, Di Tommaso L et al (2007) Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules. Cancer 109:915–923
Okazaki I, Wada N, Nakano M et al (1997) Difference in gene expression for matrix metalloproteinase-1 between early and advanced hepatocellular carcinomas. Hepatology 25:580–584
Llovet JM, Schwartz M, Mazzaferro V (2005) Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 25:181–200
Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907–1917
International Consensus Group for Hepatocellular Neoplasia (2009) Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 49:658–664
Kim MJ, Choi JY, Chung YE, Choi SY (2008) Magnetic resonance imaging of hepatocellular carcinoma using contrast media. Oncology 75(Suppl 1):72–82
Imai Y, Murakami T, Yoshida S et al (2000) Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 32:205–212
Sugihara S, Nakashima O, Kojiro M, Majima Y, Tanaka M, Tanikawa K (1992) The morphologic transition in hepatocellular carcinoma. A comparison of the individual histologic features disclosed by ultrasound-guided fine-needle biopsy with those of autopsy. Cancer 70:1488–1492
Choi BI, Kim CW, Han MC et al (1989) Sonographic characteristics of small hepatocellular carcinoma. Gastrointest Radiol 14:255–261
Onishi H, Kim T, Imai Y et al (2012) Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT. Eur Radiol 845–854
Stevens WR, Gulino SP, Batts KP, Stephens DH, Johnson CD (1996) Mosaic pattern of hepatocellular carcinoma: histologic basis for a characteristic CT appearance. J Comput Assist Tomogr 20:337–342
Jonas S, Bechstein WO, Steinmuller T et al (2001) Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 33:1080–1086
Todo S, Furukawa H (2004) Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 240:451–459
Quaglia A, Tibballs J, Grasso A et al (2003) Focal nodular hyperplasia-like areas in cirrhosis. Histopathology 42:14–21
Cuenod C, Leconte I, Siauve N et al (2001) Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT. Radiology 218:556–561
Hashimoto K, Murakami T, Dono K et al (2007) Quantitative tissue blood flow measurement of the liver parenchyma: comparison between xenon CT and perfusion CT. Dig Dis Sci 52:943–949
Cenic A, Nabavi DG, Craen RA, Gelb AW, Lee TY (1999) Dynamic CT measurement of cerebral blood flow: a validation study. Am J Neuroradiol 20:63–73
Sahani DV, Holalkere NS, Mueller PR, Zhu AX (2007) Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue—initial experience. Radiology 243:736–743
Ma SH, Le HB, Jia BH et al (2008) Peripheral pulmonary nodules: relationship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and VEGF expression. BMC Cancer 8:186
Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378–390
Ippolito D, Sironi S, Pozzi M et al (2008) Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization. Acad Radiol 15:919–927
Yanagawa M, Tomiyama N, Honda O et al (2010) Multidetector CT of the lung: image quality with garnet-based detectors. Radiology 255:944–954
Okada M, Kim T, Murakami T (2011) Hepatocellular nodules in liver cirrhosis: state of the art CT evaluation (perfusion CT/volume helical shuttle scan/dual-energy CT, etc.). Abdom Imaging 36:273–281
Schindera ST, Nelson RC, Mukundan S Jr et al (2008) Hypervascular liver tumors: low tube voltage, high tube current multi-detector row CT for enhanced detection—phantom study. Radiology 246:125–132
Graser A, Johnson TR, Bader M et al (2008) Dual energy CT characterization of urinary calculi: initial in vitro and clinical experience. Invest Radiol 43:112–119
Grosjean R, Sauer B, Guerra RM et al (2008) Characterization of human renal stones with MDCT: advantage of dual energy and limitations due to respiratory motion. Am J Roentgenol 190:720–728
Scheffel H, Stolzmann P, Frauenfelder T et al (2007) Dual-energy contrast-enhanced computed tomography for the detection of urinary stone disease. Invest Radiol 42:823–829
Primak AN, Fletcher JG, Vrtiska TJ et al (2007) Noninvasive differentiation of uric acid versus non-uric acid kidney stones using dual-energy CT. Acad Radiol 14:1441–1447
Goldberg HI, Cann CE, Moss AA, Ohto M, Brito A, Federle M (1982) Noninvasive quantitation of liver iron in dogs with hemochromatosis using dual-energy CT scanning. Invest Radiol 17:375–380
Johnson TR, Krauss B, Sedlmair M et al (2007) Material differentiation by dual energy CT: initial experience. Eur Radiol 17:1510–1517
Brooks RA (1977) A quantitative theory of the Hounsfield unit and its application to dual energy scanning. J Comput Assist Tomogr 1:487–493
Nakayama Y, Awai K, Funama Y et al (2005) Abdominal CT with low tube voltage: preliminary observations about radiation dose, contrast enhancement, image quality, and noise. Radiology 237:945–951
Yeh BM, Shepherd JA, Wang ZJ, Teh HS, Hartman RP, Prevrhal S (2009) Dual-energy and low-kVp CT in the abdomen. Am J Roentgenol 193:47–54
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Okada, M., Murakami, T. (2014). CT Imaging Characteristics of Hepatocellular Carcinoma. In: El-Baz, A., Saba, L., Suri, J. (eds) Abdomen and Thoracic Imaging. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-8498-1_12
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8498-1_12
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-8497-4
Online ISBN: 978-1-4614-8498-1
eBook Packages: MedicineMedicine (R0)